Skip to content

Clinical trials

Phase 1 Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 1 Country / region: South Korea Clear all

125 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20082
20093
20105
20115
20123
20138
201411
20157
20164
20178
20189
201910
202010
20218
20228
20237
20249
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68
Active, not recruiting24
Terminated19
Recruiting12
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie14
GlaxoSmithKline11
AstraZeneca10
Boehringer Ingelheim7
Bayer6
Novartis Pharmaceuticals5
Hoffmann-La Roche4
Merck Sharp & Dohme LLC4
Pfizer4
Sanofi4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms125
Carcinoma, Non-Small-Cell Lung37
Colorectal Neoplasms15
Neoplasm Metastasis15
Breast Neoplasms14
Squamous Cell Carcinoma of Head and Neck11
Stomach Neoplasms10
Lung Neoplasms8
Melanoma8
Ovarian Neoplasms8

Trials

Showing 1 to 25 of 125. Each trial links to its page on Pharma Observatory.

25 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.